Utility of amlodipine/atorvastatin single-pill therapy in patients with diabetes mellitus or metabolic syndrome: Results from the JEWEL programme
Main Authors: | Hobbs, R, Gensini, G, Mancini, G, Manolis, A, Bauer, B, Genest, J, Feldman, R, Harvey, P, Jenssen, T, Metcalfe, M, Da Silva, P, Grp, J |
---|---|
Format: | Conference item |
Published: |
2006
|
Similar Items
-
International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme.
by: Richard Hobbs, F, et al.
Published: (2009) -
Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program).
by: Hobbs, F, et al.
Published: (2006) -
A single-pill combination of amlodipine besylate and atorvastatin calcium (update).
by: Blank, R, et al.
Published: (2007) -
Reduction in Blood Pressure and Low-Density Lipoprotein Cholesterol When Single-Pill Amlodipine/Atorvastatin is Used as First-Line or Add-On Treatment
by: Flack, J, et al.
Published: (2009) -
Control of blood pressure and low-density lipoprotein cholesterol with single-pill amlodipine/atorvastatin: a pooled analysis of patients with and without diabetes
by: Jenssen, T, et al.
Published: (2008)